The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes

Background: Metastatic bone cancers are a significant clinical problem because metastasis disrupts normal bone homeostasis, including calcium dysregulation. Much less is known about hypocalcemia and its clinical consequences. The study analyzed serum calcium changes in metastatic bone cancer patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Khizar Memon, Syed Uzair Mahmood, Sidra Memon, Azhar Rashid, Muhammad Ali Memon, Shahzad Ali Jiskani
Format: Article
Language:English
Published: ziauddin University 2025-01-01
Series:Pakistan Journal of Medicine and Dentistry
Subjects:
Online Access:https://ojs.zu.edu.pk/pjmd/article/view/3323
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594242633990144
author Muhammad Khizar Memon
Syed Uzair Mahmood
Sidra Memon
Azhar Rashid
Muhammad Ali Memon
Shahzad Ali Jiskani
author_facet Muhammad Khizar Memon
Syed Uzair Mahmood
Sidra Memon
Azhar Rashid
Muhammad Ali Memon
Shahzad Ali Jiskani
author_sort Muhammad Khizar Memon
collection DOAJ
description Background: Metastatic bone cancers are a significant clinical problem because metastasis disrupts normal bone homeostasis, including calcium dysregulation. Much less is known about hypocalcemia and its clinical consequences. The study analyzed serum calcium changes in metastatic bone cancer patients, assessed differences across diagnoses and clinical stages, and evaluated alkaline phosphatase levels and types of bone lesions. Method: A prospective study was conducted on 100 metastatic bone cancers using convenience sampling, at Indus Medical College Hospital, between March and April 2020. The patients were categorized based on the principle tumor type, clinical stage, and bone scan results. Serum calcium, corrected calcium, albumin, and ALP are measured and analyzed using descriptive and inferential statistics. Data analysis was done by SPSS using one-way ANOVA, t-tests, Pearson correlation, regression analysis, and Chi-square tests. A p-value of <0.05 was considered significant. Results: The mean serum calcium was 8.5 ± 0.6 mg/dl. The corrected calcium level of the patients with breast cancer was statistically lower compared with the prostate cancer patients - 8.3 ± 0.5 mg/dl (p = 0.01) compared with 9.0 ± 0.6 mg/dl. The levels of ALP in blastic lesions were higher than in lytic ones, amounting to 600 ± 300 IU/L and 250 ± 100 IU/L, respectively. There was marked regression in the main diagnosis and ALP levels, which occurred with serum calcium being altered in breast cancer. Conclusion: Serum calcium levels vary significantly among different types of cancers and stages, suggesting a vigilant monitoring of calcium and ALP levels in clinical practice.
format Article
id doaj-art-cf654a6758ec4f2e90d2118fff1a7104
institution Kabale University
issn 2313-7371
2308-2593
language English
publishDate 2025-01-01
publisher ziauddin University
record_format Article
series Pakistan Journal of Medicine and Dentistry
spelling doaj-art-cf654a6758ec4f2e90d2118fff1a71042025-01-19T20:18:27Zengziauddin UniversityPakistan Journal of Medicine and Dentistry2313-73712308-25932025-01-0114110.36283/ziun-pjmd14-1/002The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient OutcomesMuhammad Khizar Memon0Syed Uzair Mahmood1Sidra Memon2Azhar Rashid3Muhammad Ali Memon4Shahzad Ali Jiskani5Allegheny Health Network, United StatesShine Humanity, Karachi, Sindh, PakistanPiedmont Macon Medical Center, GeorgiaNCCI, Karachi, Pakistan.Indus Medical College, Tando Muhammad Khan, Sindh, PakistanChandka Medical College @ SMBBMU, Larkana, Sindh, Pakistan Background: Metastatic bone cancers are a significant clinical problem because metastasis disrupts normal bone homeostasis, including calcium dysregulation. Much less is known about hypocalcemia and its clinical consequences. The study analyzed serum calcium changes in metastatic bone cancer patients, assessed differences across diagnoses and clinical stages, and evaluated alkaline phosphatase levels and types of bone lesions. Method: A prospective study was conducted on 100 metastatic bone cancers using convenience sampling, at Indus Medical College Hospital, between March and April 2020. The patients were categorized based on the principle tumor type, clinical stage, and bone scan results. Serum calcium, corrected calcium, albumin, and ALP are measured and analyzed using descriptive and inferential statistics. Data analysis was done by SPSS using one-way ANOVA, t-tests, Pearson correlation, regression analysis, and Chi-square tests. A p-value of <0.05 was considered significant. Results: The mean serum calcium was 8.5 ± 0.6 mg/dl. The corrected calcium level of the patients with breast cancer was statistically lower compared with the prostate cancer patients - 8.3 ± 0.5 mg/dl (p = 0.01) compared with 9.0 ± 0.6 mg/dl. The levels of ALP in blastic lesions were higher than in lytic ones, amounting to 600 ± 300 IU/L and 250 ± 100 IU/L, respectively. There was marked regression in the main diagnosis and ALP levels, which occurred with serum calcium being altered in breast cancer. Conclusion: Serum calcium levels vary significantly among different types of cancers and stages, suggesting a vigilant monitoring of calcium and ALP levels in clinical practice. https://ojs.zu.edu.pk/pjmd/article/view/3323Metastatic Bone Cancer Serum CalciumAlkaline PhosphataseCalcium DysregulationHypocalcemia
spellingShingle Muhammad Khizar Memon
Syed Uzair Mahmood
Sidra Memon
Azhar Rashid
Muhammad Ali Memon
Shahzad Ali Jiskani
The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
Pakistan Journal of Medicine and Dentistry
Metastatic Bone Cancer
Serum Calcium
Alkaline Phosphatase
Calcium Dysregulation
Hypocalcemia
title The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
title_full The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
title_fullStr The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
title_full_unstemmed The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
title_short The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
title_sort impact of metastatic bone cancers on serum calcium levels a focused analysis of patient outcomes
topic Metastatic Bone Cancer
Serum Calcium
Alkaline Phosphatase
Calcium Dysregulation
Hypocalcemia
url https://ojs.zu.edu.pk/pjmd/article/view/3323
work_keys_str_mv AT muhammadkhizarmemon theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT syeduzairmahmood theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT sidramemon theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT azharrashid theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT muhammadalimemon theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT shahzadalijiskani theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT muhammadkhizarmemon impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT syeduzairmahmood impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT sidramemon impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT azharrashid impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT muhammadalimemon impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes
AT shahzadalijiskani impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes